While lower-count MBL almost never progresses to CLL, high-count MBL progresses to CLL requiring therapy at a price of one% to two% per annum. Substantial-rely MBL is distinguished from Rai 0 CLL according to whether the B-mobile count is previously mentioned or under five × 109/L. Whilst men and women with the two substantial-depend MBL and CLL R